Tags:BioTech
ALX Oncology is a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint mechanism, which is exploited by cancer cells to evade the immune system.
Location: Ireland, Dublin

Investors 2

Mentions in press and media 1

DateTitleDescriptionCategoryAuthorSource
12.02.2020ALX Oncolo...The company plans to invest th...--medcitynew...